Stockreport

Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis

Natera, Inc.  (NTRA) 
Last natera, inc. earnings: 2/26 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.natera.com
PDF New genomic testing solution designed to shorten diagnostic journeys for patients and families;supports efforts to reduce the economic and societal burden of rare diseas [Read more]